Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial
暂无分享,去创建一个
J. Cavenagh | G. Cook | L. Clifton-Hadley | R. de Tute | K. Yong | R. Owen | E. Phillips | N. Rabin | R. Popat | M. Streetly | M. Koh | C. Roddie | T. C. Morris | N. Counsell | S. Schey | D. De-Silva | Josephine Crowe | T. Adedayo | Nivette Braganca | W. Y. Chan